PHAR vs JNJ: Which Stock is Better?
Side-by-side comparison of Pharming Group NV and Johnson & Johnson in 2026
PHAR
Pharming Group NV
—
JNJ
Johnson & Johnson
$263.40
Key Metrics Comparison
| Metric | PHAR | JNJ | Winner |
|---|---|---|---|
| Market Cap | $723.60M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAR
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAR or JNJ a better investment?
Comparing PHAR and JNJ: Pharming Group NV has a market cap of $723.60M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAR and JNJ?
PHAR (Pharming Group NV) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAR or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAR or JNJ?
Both PHAR and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAR or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAR or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $723.60M for PHAR.
Should I buy PHAR or JNJ in 2026?
Both PHAR and JNJ have investment merit. PHAR trades at $N/A while JNJ trades at $263.40. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAR and JNJ stock?
Key differences: Market Cap ($723.60M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAR or JNJ in 2026?
The choice between PHAR and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAR and JNJ?
PHAR (Pharming Group NV) has a market cap of $723.60M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.